- Molecular NamePyruvic acid
- Synonym2-Oxopropanoate; 2-Oxopropanoic acid; 2-Oxopropionic acid; a-Ketopropionic acid; Acetylformic acid; BTS; Pyroracemic acid; Pyruvate
- Weight88.062
- Drugbank_IDDB00119
- ACS_NO127-17-3
- Show 3D model
- LogP (experiment)-1.24
- LogP (predicted, AB/LogP v2.0)-0.65
- pkaN/A
- LogD (pH=7, predicted)-4.67
- Solubility (experiment)N/A
- LogS (predicted, ACD/Labs)(ph=7)1.06
- LogSw (predicted, AB/LogsW2.0)123.65
- Sw (mg/ml) (predicted, ACD/Labs)264.73
- No.of HBond Donors1
- No.of HBond Acceptors3
- No.of Rotatable Bonds1
- TPSA54.37
- StatusFDA approved
- AdministrationN/A
- PharmacologyThose taking large doses of supplemental pyruvate—usually greater than 5 grams daily—have reported gastrointestinal symptoms, including abdominal discomfort and bloating, gas and diarrhea. One child receiving pyruvate intravenously for restrictive cardiomyopathy died.
- Absorption_valueN/A
- Absorption (description)Pyruvate is absorbed from the gastrointestinal tract from whence it is transported to the liver via the portal circulation.
- Caco_2N/A
- BioavailabilityN/A
- Protein bindingN/A
- Volume of distribution (VD)N/A
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmIn the liver, pyruvate is metabolized via several pathways.
- Half lifeN/A
- ExcretionN/A
- Urinary ExcretionN/A
- CleranceN/A
- ToxicityN/A
- LD50 (rat)N/A
- LD50 (mouse)N/A